Mediolanum International Funds Ltd reduced its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 15.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,135 shares of the semiconductor company’s stock after selling 3,774 shares during the period. Mediolanum International Funds Ltd’s holdings in Synopsys were worth $10,262,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. Pacifica Partners Inc. purchased a new stake in shares of Synopsys during the third quarter worth $25,000. Kieckhefer Group LLC purchased a new stake in Synopsys during the 4th quarter worth about $27,000. Tsfg LLC raised its position in Synopsys by 75.0% in the 3rd quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 24 shares in the last quarter. Hazlett Burt & Watson Inc. boosted its stake in shares of Synopsys by 40.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock valued at $35,000 after buying an additional 20 shares during the period. Finally, Princeton Global Asset Management LLC acquired a new position in shares of Synopsys during the third quarter worth about $44,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on SNPS. Wells Fargo & Company reduced their target price on shares of Synopsys from $570.00 to $540.00 and set an “equal weight” rating on the stock in a report on Monday, January 13th. Piper Sandler lowered their target price on shares of Synopsys from $670.00 to $655.00 and set an “overweight” rating for the company in a report on Friday, December 6th. Loop Capital assumed coverage on shares of Synopsys in a research note on Monday, November 11th. They set a “buy” rating and a $675.00 price target on the stock. Redburn Atlantic started coverage on shares of Synopsys in a research note on Monday, January 13th. They issued a “buy” rating and a $600.00 price objective for the company. Finally, Berenberg Bank began coverage on Synopsys in a research report on Tuesday, October 15th. They set a “buy” rating and a $660.00 target price on the stock. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of “Moderate Buy” and a consensus price target of $641.82.
Synopsys Stock Down 0.2 %
Shares of SNPS stock opened at $525.48 on Friday. Synopsys, Inc. has a 52-week low of $457.52 and a 52-week high of $629.38. The stock’s 50-day moving average price is $517.05 and its 200 day moving average price is $521.58. The stock has a market capitalization of $81.23 billion, a PE ratio of 36.19, a price-to-earnings-growth ratio of 3.36 and a beta of 1.12.
Insider Activity
In related news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.66% of the company’s stock.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Consumer Discretionary Stocks Explained
- Nebius Group: Market Overreaction or Real AI Disruption?
- What is the Dow Jones Industrial Average (DJIA)?
- The Best Way to Invest in Gold Is…
- Best Stocks Under $10.00
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.